{"id":"https://openalex.org/W4367303689","doi":"https://doi.org/10.1212/wnl.0000000000203971","title":"Preclinical Proof-of-concept of a Novel AAV9-microRNA based Targeting of GRIK2 for the Treatment of Temporal Lobe Epilepsy (S44.001)","display_name":"Preclinical Proof-of-concept of a Novel AAV9-microRNA based Targeting of GRIK2 for the Treatment of Temporal Lobe Epilepsy (S44.001)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367303689","doi":"https://doi.org/10.1212/wnl.0000000000203971"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000203971","doi":"https://doi.org/10.1212/wnl.0000000000203971","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203971","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008336617","display_name":"Nick Pearson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nick Pearson","raw_affiliation_strings":["Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040876257","display_name":"St\u00e9phane J. Baudouin","orcid":"https://orcid.org/0000-0001-6902-6071","observed_orcids":["https://orcid.org/0000-0001-6902-6071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephane Baudouin","raw_affiliation_strings":["Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005175159","display_name":"Morgane Wartel","orcid":"https://orcid.org/0000-0002-4955-7972","observed_orcids":["https://orcid.org/0000-0002-4955-7972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morgane Wartel","raw_affiliation_strings":["uniQure biopharma B.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"uniQure biopharma B.V","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073263189","display_name":"Sonay Keskin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonay Keskin","raw_affiliation_strings":["uniQure biopharma B.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"uniQure biopharma B.V","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105416523","display_name":"Olivier Danos","orcid":"https://orcid.org/0000-0003-2202-4540","observed_orcids":["https://orcid.org/0000-0003-2202-4540"]},"institutions":[{"id":"https://openalex.org/I4210090650","display_name":"Regenxbio (United States)","ror":"https://ror.org/009df1343","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090650"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivier Danos","raw_affiliation_strings":["REGENXBIO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"REGENXBIO","institution_ids":["https://openalex.org/I4210090650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077824291","display_name":"Christophe Mulle","orcid":"https://orcid.org/0000-0003-2709-6615","observed_orcids":["https://orcid.org/0000-0003-2709-6615"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I4210133144","display_name":"Institut Interdisciplinaire de Neuroscience","ror":"https://ror.org/032j53342","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I15057530","https://openalex.org/I4210096427","https://openalex.org/I4210133144"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Mulle","raw_affiliation_strings":["Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, F-33000","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210133144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047229925","display_name":"Nicolas Partouche","orcid":"https://orcid.org/0000-0002-2092-6017","observed_orcids":["https://orcid.org/0000-0002-2092-6017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicolas Partouche","raw_affiliation_strings":["Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012500628","display_name":"Val\u00e9rie Cr\u00e9pel","orcid":"https://orcid.org/0000-0003-0408-3766","observed_orcids":["https://orcid.org/0000-0003-0408-3766"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210125028","display_name":"Institut de Neurobiologie de la M\u00e9diterran\u00e9e","ror":"https://ror.org/02jthx987","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210125028"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Val\u00e9rie Cr\u00e9pel","raw_affiliation_strings":["Aix-Marseille Univ. INSERM, INMED"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aix-Marseille Univ. INSERM, INMED","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210125028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015740938","display_name":"Andreas Borta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Borta","raw_affiliation_strings":["Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074697883","display_name":"Richard Porter","orcid":"https://orcid.org/0000-0002-8695-3966","observed_orcids":["https://orcid.org/0000-0002-8695-3966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Porter","raw_affiliation_strings":["Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corlieve Therapeutics SAS, France, a wholly-owned subsidiary of uniQure N.V","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4849,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.58167521,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temporal-lobe-epilepsy","display_name":"temporal lobe epilepsy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/grik2","display_name":"GRIK2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/kainate-receptors","display_name":"kainate receptors","score":0.7950000166893005},{"id":"https://openalex.org/keywords/aav9","display_name":"AAV9","score":0.6930000185966492},{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.8339999914169312},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.9599999785423279},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.8629999756813049},{"id":"https://openalex.org/keywords/anticonvulsant-therapy","display_name":"anticonvulsant therapy","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.780386209487915},{"id":"https://openalex.org/C2781099131","wikidata":"https://www.wikidata.org/wiki/Q744385","display_name":"Temporal lobe","level":3,"score":0.7161788940429688},{"id":"https://openalex.org/C189184402","wikidata":"https://www.wikidata.org/wiki/Q3454536","display_name":"Kainate receptor","level":5,"score":0.6885612607002258},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.633682370185852},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.5805317759513855},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.4881182610988617},{"id":"https://openalex.org/C2779296341","wikidata":"https://www.wikidata.org/wiki/Q1500732","display_name":"Interneuron","level":3,"score":0.4542742669582367},{"id":"https://openalex.org/C2776108384","wikidata":"https://www.wikidata.org/wiki/Q390239","display_name":"Kainic acid","level":4,"score":0.44937872886657715},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3769848346710205},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37399929761886597},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.33533236384391785},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.2320813238620758},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22909533977508545},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18838068842887878},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.10580149292945862}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000203971","doi":"https://doi.org/10.1212/wnl.0000000000203971","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203971","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402659947","https://openalex.org/W4381470391","https://openalex.org/W2021903785","https://openalex.org/W6925296636","https://openalex.org/W3164288424","https://openalex.org/W4310243175","https://openalex.org/W3087494170","https://openalex.org/W2036342434","https://openalex.org/W2063906832","https://openalex.org/W7099455310"],"abstract_inverted_index":{"The":[0],"objective":[1],"of":[2,12],"this":[3],"study":[4],"was":[5],"to":[6],"determine":[7],"if":[8],"lowering":[9],"the":[10,13],"expression":[11],"Glutamate":[14],"Ionotropic":[15],"Receptor":[16],"Kainate":[17],"Type":[18],"Subunit":[19],"2":[20],"(GRIK2)":[21],"using":[22],"RNA":[23],"interference":[24],"can":[25],"be":[26],"a":[27],"therapeutic":[28],"strategy":[29],"for":[30],"temporal":[31],"lobe":[32],"epilepsy":[33],"(TLE).":[34]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2023-04-29T00:00:00"}